Measurement of (1→3)-β-D-glucan in an experimental model of systemic candidiasis

被引:3
|
作者
Kawagoe, T
Nakao, A
Kanbe, T
Tamura, H
Tanaka, S
Takagi, H
机构
[1] Nagoya Univ, Sch Med, Dept Surg 2, Showa Ku, Nagoya, Aichi 466, Japan
[2] Seikagaku Kogyo Co Ltd, Tokyo, Japan
关键词
candidiasis; (1 -> 3)-beta-D-glucan; limulus factor G;
D O I
10.1159/000008589
中图分类号
R61 [外科手术学];
学科分类号
摘要
To investigate the utility of measuring blood concentrations of (1 --> 3)-beta-D-glucan, a component of the fungal cell wall, as an auxiliary diagnostic method for systemic candidiasis, rats were inoculated with Candida albicans and the number of C. albicans in the viscera and glucan in the blood were quantitated, The concentration of blood glucan and the number of C. albicans in the viscera were also measured both under leukopenia and with deteriorated reticuloendothelial system cell function, and when the liver and spleen had been excised, As a result, systemic candidiasis appeared in the group with leukopenia, and the number of living C. albicans increased in the kidney and liver. Together with this increase in the number of C. albicans, there was an increase in blood (1 --> 3)-beta-D-glucan. Measurements of blood (1 --> 3)-beta-D-glucan well reflect a proliferation of C. albicans in vivo, which would make this a useful auxiliary for the clinical diagnosis of systemic mycosis.
引用
收藏
页码:290 / 296
页数:7
相关论文
共 50 条
  • [1] β-D-Glucan Assay in Diagnosis and Monitoring the Systemic Candidiasis in a Rat Model
    Khodadadi, Hossein
    Mirhendi, Hossein
    Makimura, Koichi
    Satoh, Kazuo
    Karimi, Ladan
    Izadi, Shahrokh
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2014, 7 (06)
  • [2] Interference of (1→3)-β-D-glucan Administration in the Measurement of Plasma (1→3)-β-D-glucan
    Ishizuka, Y
    Tsukada, H
    Gejyo, F
    INTERNAL MEDICINE, 2004, 43 (02) : 97 - 101
  • [3] Serum (1→3)-β-D-Glucan Measurement in Coccidioidomycosis
    Thompson, George R., III
    Bays, Derek J.
    Johnson, Suzanne M.
    Cohen, Stuart H.
    Pappagianis, Demosthenes
    Finkelman, Malcolm A.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (09) : 3060 - 3062
  • [4] (1,3)-β-D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis
    Jaijakul, Siraya
    Vazquez, Jose A.
    Swanson, Robert N.
    Ostrosky-Zeichner, Luis
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (04) : 521 - 526
  • [5] (1-3)-β-D-glucan levels in candidiasis infections in the critically ill neonate
    Goudjil, Sabrina
    Kongolo, Guy
    Dusol, Lucie
    Imestouren, Fatiha
    Cornu, Marjorie
    Leke, Andre
    Chouaki, Taieb
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2013, 26 (01): : 44 - 48
  • [6] (1→3) β-D-Glucan as a Prognostic Marker
    Chow, Harry
    Hurley, James C.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (03) : 466 - 466
  • [7] Overview of (1→3)-β-D-glucan immunobiology
    Williams, DL
    MEDIATORS OF INFLAMMATION, 1997, 6 (04) : 247 - 250
  • [8] A novel enzyme immunoassay for the measurement of plasma (1 → 3)-β-D-glucan levels
    Sunamura, Ei-ichiro
    Iwasaki, Manami
    Shiina, Shota
    Kitahara, Shin-ichiro
    Yotani, Takuya
    Manabe, Mitsuhisa
    Miyazaki, Osamu
    JOURNAL OF IMMUNOLOGICAL METHODS, 2020, 487
  • [9] Inhalation of (1→3)-β-D-glucan in humans
    Beijer, L
    Thorn, J
    Rylander, R
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A856 - A856
  • [10] Prognostic value of serial (1,3)-β-D-glucan measurements in ICU patients with invasive candidiasis
    Carelli, Simone
    Posteraro, Brunella
    Torelli, Riccardo
    De Carolis, Elena
    Vallecoccia, Maria Sole
    Xhemalaj, Rikardo
    Cutuli, Salvatore Lucio
    Tanzarella, Eloisa Sofia
    Dell'Anna, Antonio Maria
    Lombardi, Gianmarco
    Cammarota, Fabiola
    Caroli, Alessandro
    Grieco, Domenico Luca
    Sanguinetti, Maurizio
    Antonelli, Massimo
    De Pascale, Gennaro
    CRITICAL CARE, 2024, 28 (01)